n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane has been researched along with selegiline in 3 studies
| Studies (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Trials (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Recent Studies (post-2010) (n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane) | Studies (selegiline) | Trials (selegiline) | Recent Studies (post-2010) (selegiline) |
|---|---|---|---|---|---|
| 33 | 1 | 19 | 2,575 | 319 | 394 |
| Protein | Taxonomy | n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane (IC50) | selegiline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0055 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0039 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.798 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.376 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.2127 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.9046 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.4408 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0067 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1001 | |
| Type-1 angiotensin II receptor | Sus scrofa (pig) | 0.048 | |
| Alpha-synuclein | Homo sapiens (human) | 0.27 | |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | 1 | |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelemen, K; Knoll, B; Knoll, J; Markó, R; Miklya, I | 1 |
| Knoll, J | 1 |
| Knoll, B; Knoll, J; Miklya, I | 1 |
1 review(s) available for n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane and selegiline
| Article | Year |
|---|---|
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
Topics: Aging; Alzheimer Disease; Animals; Benzofurans; Brain; Catecholamines; Depression; Humans; Neuroprotective Agents; Parkinson Disease; Propylamines; Selegiline; Serotonin | 2001 |
2 other study(ies) available for n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane and selegiline
| Article | Year |
|---|---|
(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons.
Topics: Action Potentials; Animals; Brain; Brain Stem; Catecholamines; Dose-Response Relationship, Drug; Female; Male; Neurons; Neurotransmitter Agents; Norepinephrine; Propylamines; Rana esculenta; Rats; Rats, Wistar; Selegiline; Stimulation, Chemical; Tritium | 1996 |
An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats.
Topics: Amphetamine; Animals; Benzofurans; Brain Chemistry; Catecholamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Drive; Feeding Behavior; Food Deprivation; Hunger; Male; Monoamine Oxidase Inhibitors; Motor Activity; Neurons; Neurotransmitter Agents; Orientation; Propylamines; Rats; Rats, Wistar; Selegiline; Serotonin | 2003 |